What to Expect When Starting Levalbuterol
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Levalbuterol (Xopenex) is a short-acting beta-2 agonist (SABA) used for relief of bronchospasm in asthma and COPD. It is the R-enantiomer of albuterol, purported to provide bronchodilation with less of the cardiac stimulant effect. It works within 5-15 minutes and provides relief for 4-6 hours. Like albuterol, it is a rescue inhaler — not a controller medication — and should not be needed more than twice weekly in well-controlled asthma.
Week-by-week timeline
First Use — Relief Inhaler
Levalbuterol works within 5-15 minutes of inhalation. Use it when you have acute shortness of breath, wheezing, chest tightness, or cough. For adults: 1-2 puffs every 4-8 hours as needed. Common side effects: trembling, jitteriness, rapid heart rate, headache — these are dose-dependent and typical of beta-2 agonists.
Understanding Rescue Use
Track how often you use your rescue inhaler each week. In well-controlled asthma, rescue use should be no more than 2 days per week. Needing it more frequently suggests asthma is not well controlled and a controller medication (inhaled corticosteroid) may be needed or your current controller therapy may need adjustment.
Usage Pattern Assessment
Discuss your levalbuterol use frequency with your prescriber at each visit. Increased rescue inhaler use is a key indicator of poor asthma control and should prompt treatment step-up. Levalbuterol is not a substitute for daily controller therapy.
Role Within Asthma Action Plan
Your asthma action plan should specify when to use your rescue inhaler, when to increase controller therapy, and when to seek emergency care. Levalbuterol has a role in the 'yellow zone' of most action plans.
Ongoing Monitoring
If you have an asthma action plan and use levalbuterol properly within it, emergency visits and hospitalizations should be minimized. Regularly check that your inhaler is not expired and that you have a filled prescription — never run out of your rescue inhaler.
When to call your doctor
Contact your healthcare provider if you experience:
- Worsening shortness of breath despite using levalbuterol (possible severe exacerbation — seek emergency care)
- No improvement after 2-4 puffs during an acute attack (go to emergency room or call 911)
- Rapid or irregular heartbeat that is new or worsening
- Severe chest pain during or after using levalbuterol
- Significantly increased need for rescue inhaler (more than 2 days per week) — call prescriber for treatment adjustment
- Paradoxical bronchospasm: wheezing worsens immediately after using inhaler — use a different inhaler and seek care
- Signs of low potassium with frequent use: muscle cramps, weakness, irregular heartbeat
Tips for getting started
Use your rescue inhaler for acute symptoms only — not as a scheduled daily medication. If you need it more than twice a week, contact your prescriber, as this indicates poor asthma control requiring treatment adjustment. Shake the inhaler well before each use. Prime before first use (4 puffs into air) and after non-use for 3+ days. Use a spacer with the MDI for better lung delivery and reduced mouth deposition. Check expiration dates regularly and always have a filled spare. Rinse your mouth after use to reduce throat irritation.
Frequently asked questions
More about Levalbuterol
References
- [Regulatory] FDA Label: Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021602lbl.pdf Accessed 2026-03-01.
- [Regulatory] NIH MedlinePlus: Levalbuterol Inhalation https://medlineplus.gov/druginfo/meds/a603025.html Accessed 2026-03-01.
- [Regulatory] GINA Asthma Management Guidelines: Rescue Bronchodilators https://ginasthma.org/gina-reports/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: